Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00039780
Status:
COMPLETED
Last Update Posted:
2022-07-13
First Post:
2002-06-10
Brief Title:
Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel
Sponsor:
BioNumerik Pharmaceuticals Inc
Organization:
BioNumerik Pharmaceuticals Inc
Organization Data
Organization:
BioNumerik Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
DMS30203R
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BioNumerik Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Lantern Pharma Inc became Sponsor of Tavocept BNP7787 IND 051014 as of March 26 2019 | UNKNOWN |